OTCPK:PTPI (USA)
Â
Ordinary Shares
$
0.0046
+0.000010 (+0.22%)
10:08 PM EST
Business Description
Petros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US71678J3086
Share Class Description:
PTPI: Ordinary SharesTotal Employee Number:
3Description
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.4 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 90 | |||||
3-Year EPS without NRI Growth Rate | 77.5 | |||||
3-Year FCF Growth Rate | 88.4 | |||||
3-Year Book Growth Rate | -93 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 44.32 | |||||
9-Day RSI | 40.32 | |||||
14-Day RSI | 39.89 | |||||
3-1 Month Momentum % | -25.31 | |||||
6-1 Month Momentum % | -24.38 | |||||
12-1 Month Momentum % | -78.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.68 | |||||
Quick Ratio | 1.68 | |||||
Cash Ratio | 1.66 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -698.7 | |||||
Shareholder Yield % | 106.25 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | 554.47 | |||||
ROA % | 39.15 | |||||
ROIC % | -92.45 | |||||
3-Year ROIIC % | -63.16 | |||||
ROC (Joel Greenblatt) % | -19136.36 | |||||
ROCE % | -187.58 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 0.11 | |||||
Price-to-Tangible-Book | 0.11 | |||||
EV-to-EBIT | 0.35 | |||||
EV-to-EBITDA | 0.35 | |||||
EV-to-Forward-Revenue | 1.18 | |||||
EV-to-FCF | 0.25 | |||||
| Price-to-Net-Current-Asset-Value | 0.11 | |||||
| Price-to-Net-Cash | 0.11 | |||||
Earnings Yield (Greenblatt) % | 285.71 | |||||
FCF Yield % | -3051.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PTPI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Petros Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.156 | ||
| Beta | 2.463 | ||
| 3-Year Sharpe Ratio | -1.51 | ||
| 3-Year Sortino Ratio | -1.68 | ||
| Volatility % | 64.52 | ||
| 14-Day RSI | 39.89 | ||
| 14-Day ATR ($) | 0.001127 | ||
| 20-Day SMA ($) | 0.005072 | ||
| 12-1 Month Momentum % | -78.99 | ||
| 52-Week Range ($) | 0.0017 - 0.0327 | ||
| Shares Outstanding (Mil) | 42.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Petros Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Petros Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.04:1 Stock Split | 2025-05-01 | 0.30 (-25.47%) | ||
| 0.1:1 Stock Split | 2022-12-01 | 102.78 (-0.96%) |
Show
Entries
Petros Pharmaceuticals Inc Frequently Asked Questions
What is Petros Pharmaceuticals Inc(PTPI)'s stock price today?
The current price of PTPI is $0.00. The 52 week high of PTPI is $0.03 and 52 week low is $0.00.
When is next earnings date of Petros Pharmaceuticals Inc(PTPI)?
The next earnings date of Petros Pharmaceuticals Inc(PTPI) is .
Does Petros Pharmaceuticals Inc(PTPI) pay dividends? If so, how much?
Petros Pharmaceuticals Inc(PTPI) does not pay dividend.
Guru Commentaries on OTCPK:PTPI
No articles.
Press Release
Articles on Petros Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers